Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-16

Clinical Trial Update: An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation

View source ↗

Summary

An observational study evaluating how well Eligard (leuprolide acetate) works and its tolerability in patients with advanced prostate cancer in Russia; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eligard (leuprolide acetate)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Advanced Prostate Carcinoma | Status: COMPLETED